dc.creatorMenéndez, M.
dc.creatorRumie, K.
dc.creatorGarcía, H.
dc.date.accessioned2020-01-12T03:37:26Z
dc.date.available2020-01-12T03:37:26Z
dc.date.created2020-01-12T03:37:26Z
dc.date.issued2011
dc.identifier10.4067/S0370-41062011000500009
dc.identifier0370-4106
dc.identifierhttps://repositorio.uc.cl/handle/11534/27366
dc.description.abstractTurner's Syndrome is the most frequent cause of female hypogonadism. Puberty must be pharmacologically induced in over 80% of these girls. Induction must be completed in a manner closest to physiology as possible. It is recommended that this induction be initiated at age 12 y.o. with natural estrogens (17 beta estradiol) in low dosage, equivalent to 1/10 a 1/8 of substitution dose, increasing stepwise and adding, after two years, a progestin to generate a menstruation. This revision shows various proposed schemes, as well as therapeutic alternatives available in Chile.
dc.languageen
dc.subjectHypogonadism
dc.subjectPuberty
dc.subjectTurner
dc.subjectEstradiol
dc.subjectGestagen
dc.subjectArticle
dc.subjectHormone substitution
dc.subjectHuman
dc.subjectMenstruation
dc.subjectTurner syndrome
dc.titleInduction of puberty in Turner's syndrome
dc.typeartículo


Este ítem pertenece a la siguiente institución